Drug Research

On May 20, 2024, AstraZeneca, the global biopharma company, announced plans to build a $1.5 billion manufacturing facility in Singapore. With this announcement, the company is looking to start the design and construction of the new Singapore setup by...

The FDA’s final rule that solidifies its presence and authority on Laboratory-Developed Tests- LDTs goes on to mark a prominent shift in the regulation as far as the diagnostics sector is concerned. The rule very well makes it pretty clear...

AbbVie and Gilgamesh Pharmaceuticals entered a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's research platform to discover novel neuroplastogens. Under the agreement, the companies have agreed...

Fulcrum Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing small molecules, has entered into a collaboration and license agreement with Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of...

Aldevron, a global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, has entered a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery systems for...

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays that predict and evaluate potential risks of preclinical immunogenicity in protein, antibody, and gene...

ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-use products in Speke, Liverpool, to address an increased demand in the market for disposable technologies and equipment. The new...